Health Care & Life Sciences » Pharmaceuticals » Top pharmaceutical drugs | Top oncology products by revenue globally 2017-2024

Top 5 worldwide oncology products by revenue 2017 and 2024

Top 5 oncology products worldwide based on revenue in 2017 and 2024 (Figures expressed in millions of U.S. dollars, unless otherwise specified)

The data shows the oncology products (cancer drugs) worldwide ranked by projected revenue in 2024, and their revenues in 2017. The drug Opdivo from Bristol-Myers and Squibb is expected to generate around 11.2 billion USD in revenue in 2024. Oncology deals with cancer, including diagnosis, therapy, as well as palliative care.

Keytruda (Merck & Co) 3823 12686
Revlimid (Celgene) 8191 11931
Opdivo (BMS) 5725 11247
Imbruvica (J&J/Pharmacyclics) 3196 9557
Ibrance (Pfizer) 3126 8284

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.